Dimerization of the pulmonary surfactant protein C in a membrane environment.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 05 01 2022
accepted: 01 04 2022
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 30 4 2022
Statut: epublish

Résumé

Surfactant protein C (SP-C) has several functions in pulmonary surfactant. These include the transfer of lipids between different membrane structures, a role in surfactant recycling and homeostasis, and involvement in modulation of the innate defense system. Despite these important functions, the structures of functional SP-C complexes have remained unclear. SP-C is known to exist as a primarily α-helical structure with an apparently unstructured N-terminal region, yet there is recent evidence that the functions of SP-C could be associated with the formation of SP-C dimers and higher oligomers. In this work, we used molecular dynamics simulations, two-dimensional umbrella sampling, and well-tempered metadynamics to study the details of SP-C dimerization. The results suggest that SP-C dimerizes in pulmonary surfactant membranes, forming dimers of different topologies. The simulations identified a dimerization motif region V21xxxVxxxGxxxM33 that is much larger than the putative A30xxxG34 motif that is commonly assumed to control the dimerization of some α-helical transmembrane domains. The results provide a stronger basis for elucidating how SP-C functions in concert with other surfactant proteins.

Identifiants

pubmed: 35476695
doi: 10.1371/journal.pone.0267155
pii: PONE-D-21-41017
pmc: PMC9045638
doi:

Substances chimiques

Pulmonary Surfactant-Associated Protein C 0
Pulmonary Surfactant-Associated Proteins 0
Pulmonary Surfactants 0
Surface-Active Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0267155

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biophys J. 1997 Jun;72(6):2638-50
pubmed: 9168039
Eur Respir Rev. 2012 Jun 1;21(124):152-60
pubmed: 22654088
J Biol Chem. 2018 Jun 15;293(24):9399-9411
pubmed: 29700110
J Chem Theory Comput. 2014 Jun 10;10(6):2577-82
pubmed: 26580777
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Biophys J. 2015 Oct 20;109(8):1528-32
pubmed: 26488642
PLoS Comput Biol. 2017 Oct 30;13(10):e1005831
pubmed: 29084218
Chem Phys Lipids. 2006 Jun;141(1-2):105-18
pubmed: 16600200
Eur J Biochem. 1997 Mar 15;244(3):675-93
pubmed: 9108235
Biochemistry. 1995 Mar 28;34(12):3964-71
pubmed: 7696261
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
Eur J Biochem. 2004 Jun;271(11):2086-92
pubmed: 15153098
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):79-89
pubmed: 9813251
Chest. 2002 Mar;121(3 Suppl):20S-21S
pubmed: 11893657
Trends Biochem Sci. 2002 Jul;27(7):329-32
pubmed: 12114016
J Chem Theory Comput. 2008 May;4(5):819-34
pubmed: 26621095
Biochim Biophys Acta. 2013 Aug;1828(8):1829-33
pubmed: 23562404
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Am J Respir Crit Care Med. 2008 Oct 15;178(8):838-46
pubmed: 18635891
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1676-95
pubmed: 18515069
Biochemistry. 1994 May 17;33(19):6015-23
pubmed: 8180229
Biophys J. 2006 Apr 15;90(8):2698-705
pubmed: 16443648
Biophys J. 1996 Jul;71(1):246-56
pubmed: 8804608
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
pubmed: 9895674
J Comput Chem. 2009 Oct;30(13):2157-64
pubmed: 19229944
Biophys J. 2016 Oct 18;111(8):1703-1713
pubmed: 27760357
Ann Anat. 2017 Jan;209:78-92
pubmed: 27773772
Biochim Biophys Acta. 2014 Jun;1838(6):1568-85
pubmed: 24525076
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6366-71
pubmed: 11344267
Swiss Med Wkly. 2003 May 17;133(19-20):275-82
pubmed: 12844270
Biophys J. 2008 Feb 15;94(4):1542-3; discussion 1544
pubmed: 18055534
Biochim Biophys Acta Biomembr. 2021 Jun 1;1863(6):183572
pubmed: 33548215
FEBS Lett. 2005 Mar 14;579(7):1633-8
pubmed: 15757653
J Pediatr. 2001 Jul;139(1):85-92
pubmed: 11445799
N Engl J Med. 2001 Feb 22;344(8):573-9
pubmed: 11207353
J Chem Inf Model. 2015 Oct 26;55(10):2206-17
pubmed: 26397014
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Eur Respir J. 2004 Jul;24(1):30-9
pubmed: 15293602
J Chem Theory Comput. 2013 Jan 8;9(1):687-97
pubmed: 26589065
J Phys Chem B. 2007 Jul 12;111(27):7812-24
pubmed: 17569554

Auteurs

Hanna Korolainen (H)

Department of Physics, University of Helsinki, Helsinki, Finland.

Fabio Lolicato (F)

Department of Physics, University of Helsinki, Helsinki, Finland.
Heidelberg University Biochemistry Center, Heidelberg, Germany.

Giray Enkavi (G)

Department of Physics, University of Helsinki, Helsinki, Finland.

Jesús Pérez-Gil (J)

Faculty of Biology, Department of Biochemistry and Molecular Biology, Research Institute "Hospital 12 de Octubre (imas12)", Complutense University, Madrid, Spain.

Waldemar Kulig (W)

Department of Physics, University of Helsinki, Helsinki, Finland.

Ilpo Vattulainen (I)

Department of Physics, University of Helsinki, Helsinki, Finland.

Articles similaires

Surface-Active Agents Soil Microbiology Soil Pollutants Aspergillus Aspergillus niger
Humans DNA, Viral Sodium Dodecyl Sulfate Hepatitis B virus Benzenesulfonates
1.00
Surface-Active Agents Amino Acids Biocatalysis Amidohydrolases Substrate Specificity
Humans Respiratory Distress Syndrome, Newborn Infant, Newborn Female Risk Factors

Classifications MeSH